Skip to main content
Singapore Clinical Research Institute will NEVER ask you to transfer money or disclose bank details over a call.

If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg (opens in new tab).

Singapore Clinical Research Institute (SCRI)

Prof Shih Chun Che

Meet Prof Shih Chun-Che, a leading cardiovascular surgeon and researcher with over 30 years of experience in heart surgery, stem cell therapy, and vascular innovation.

Last updated on 25 May 2026
Middle-aged East Asian man with glasses and dark jacket, smiling slightly against a white background.

Prof Shih Chun-Che

Prof. Shih Chun-Che is Executive Vice President of Taipei Medical University (TMU) and Director of the Taipei Heart Institute. He also serves as Professor of Surgery at TMU’s School of Medicine. With over three decades of experience, he specializes in heart transplantation, end-stage heart disease surgery, valve repair, and minimally invasive endovascular treatment for aortic dissection. Prof. Shih earned his M.D. from China Medical University and a Ph.D. from National Yang-Ming University. He previously served as Chief and Attending Surgeon in Cardiovascular Surgery at Taipei Veterans General Hospital.

Prof. Shih has led numerous research initiatives, including clinical trials on mesenchymal stem cell therapy for critical limb ischemia and nanotechnology applications in cardiovascular medicine. His groundbreaking work has been published extensively in high-impact international journals. He is a frequent faculty member at the prestigious VEITH Symposium and other international cardiovascular conferences.

In recognition of his contributions, Prof. Shih has received multiple awards, including the Medical Device Innovation Award from Taiwan FDA, the Special Contribution Award for Pandemic Prevention, the Distinguished Physician Award from Taipei Medical Association, and the International Lifetime Achievement Award from the Society for Vascular Surgery (USA). He continues to be an influential leader in cardiovascular innovation, clinical excellence, and medical education.